Nasal spray shows promise for Hard-to-Control asthma
NCT ID NCT05985694
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This study tested a nasal spray called AD17002 in 40 adults with moderate to severe eosinophilic asthma that was not well controlled. Participants used the spray twice a week for 6 weeks. The goal was to see if the spray could improve lung function and reduce the need for rescue inhalers, while also checking its safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Taipei Medical University Hospital
Taipei, Taiwan, Taiwan
Conditions
Explore the condition pages connected to this study.